Access cutting-edge solid tumors treatment through this clinical trial at a research site in San Antonio. Study-provided care at no cost to qualified participants.
Access solid tumors specialists in San Antonio at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumors treatment provided free
The study treatment, BAY 3713372, is under development to treat MTAP (methylthioadenosine phosphorylase)-deleted solid tumors. It is thought to work by blocking the protein arginine N-methyltransferase 5 (PRMT5). This may kill the MTAP-deleted cancer cells while sparing the normal cells. The main objective of this first-in-human study is to learn how safe BAY 3713372 is, how the body processes it, and how well it works in people with MTAP-deleted solid tumors. For this, the researchers will st
Sponsor: Bayer
Check if you qualify for this solid tumors clinical trial in San Antonio, TX
If you're searching for solid tumors treatment options in San Antonio, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Antonio research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.